Identifying potential tumor markers and antigens by database mining and rapid expression screening

被引:79
作者
Loging, WT
Lal, A
Siu, IM
Loney, TL
Wikstrand, CJ
Marra, MA
Prange, C
Bigner, DD
Strausberg, RL
Riggins, GJ [1 ]
机构
[1] Duke Univ, Med Ctr, Durham, NC 27710 USA
[2] Washington Univ, Genome Sequencing Ctr, St Louis, MO 63108 USA
[3] Univ Calif Lawrence Livermore Natl Lab, Biol & Biotechnol Res Program, IMAGE Consortium, Livermore, CA 94550 USA
[4] NCI, Canc Genome Anat Project, Off Director, Bethesda, MD 20892 USA
关键词
D O I
10.1101/gr.138000
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Genes expressed specifically in malignant tissue may have potential as therapeutic targets but have been difficult to locate for most cancers. The information hidden within certain public databases can reveal RNA transcripts specifically expressed in transformed tissue. To be useful, database information must be verified and a more complete pattern of tissue expression must be demonstrated. We tested database mining plus rapid screening by fluorescent-PCR expression comparison (F-PEC) as an approach to locate candidate brain tumor antigens. Cancer Genome Anatomy Project (CGAP) data was mined for genes highly expressed in glioblastoma multiforme. From 13 mined genes, seven showed potential as possible tumor markers or antigens as determined by further expression profiling. Now that large-scale expression information is readily available for many of the commonly occurring cancers, other candidate tumor markers or antigens could be located and evaluated with this approach.
引用
收藏
页码:1393 / 1402
页数:10
相关论文
共 47 条
[1]   RAPID CDNA SEQUENCING (EXPRESSED SEQUENCE TAGS) FROM A DIRECTIONALLY CLONED HUMAN INFANT BRAIN CDNA LIBRARY [J].
ADAMS, MD ;
SOARES, MB ;
KERLAVAGE, AR ;
FIELDS, C ;
VENTER, JC .
NATURE GENETICS, 1993, 4 (04) :373-386
[2]   Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues [J].
Ahn, SH ;
Sawada, H ;
Ro, JY ;
Nicolson, GL .
CLINICAL & EXPERIMENTAL METASTASIS, 1997, 15 (02) :151-156
[3]  
AKSOY S, 1994, J BIOL CHEM, V269, P14835
[4]  
[Anonymous], 2000, World Health Organisation Classification of Tumours: Pathology and genetics of tumours of the nervous system
[5]   Dendritic cells: development, function and potential use for cancer immunotherapy [J].
Avigan, D .
BLOOD REVIEWS, 1999, 13 (01) :51-64
[6]   Development of dendritic cells and their use in tumor therapy [J].
Björck, P .
CLINICAL IMMUNOLOGY, 1999, 92 (02) :119-127
[7]   Quantitative RT-PCR: Pitfalls and potential [J].
Freeman, WM ;
Walker, SJ ;
Vrana, KE .
BIOTECHNIQUES, 1999, 26 (01) :112-+
[8]   Immunotherapy of cancer with dendritic-cell-based vaccines [J].
Gilboa, E ;
Nair, SK ;
Lyerly, HK .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1998, 46 (02) :82-87
[9]  
Greenfield JJA, 1999, J CELL SCI, V112, P1477
[10]   HYBRIDIZATION FINGERPRINTING OF HIGH-DENSITY CDNA-LIBRARY ARRAYS WITH CDNA POOLS DERIVED FROM WHOLE TISSUES [J].
GRESS, TM ;
HOHEISEL, JD ;
LENNON, GG ;
ZEHETNER, G ;
LEHRACH, H .
MAMMALIAN GENOME, 1992, 3 (11) :609-619